Respiratory Infections

A daily summary of our COVID-19 coverage.

The wearable technology is now authorized to monitor patients for changes in QT interval. Investigational drugs being administered to COVID-19 patients, such as chloroquine and hydroxychloroquine, can cause prolongation of QT intervals and life-threatening arrhythmias.

Virologists have taken marketed drugs from in-vitro screening for potential to repurpose for SARS-CoV-2 to in-vivo results in animal model.

Cornelius J. Clancy, MD, discusses navigating partial trial information and the need for coherent national coordination on the COVID-19 response.

Commentary outlines “best practices” for studies looking into possible treatments, vaccine.

A brief summary of our daily COVID-19 coverage.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The FDA has added a ventilator developed by NASA to the list of authorized ventilators.

A round up of the top infectious disease news from April.

How closely related were the RSV strains in a Louisiana NICU outbreak?

A review of our latest COVID-19 coverage.

Treatment with remdesivir was not associated with statistically significant clinical benefits. However, the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.

Michael K. Gusmano, PhD, discusses the importance of maintaining ethical standards in research evaluating potential therapeutics and vaccines for COVID-19.

A New York City nurse reflects on "peak-week" in a COVID unit.

The SIMPLE trial appears to have demonstrated that patients receiving the 5-day dose duration achieved similar improvement in clinical status compared to patients who received the 10-day dosing duration.

A daily round up of our COVID-19 coverage.

Hollis O’Neal, MD, the national primary investigator for the Cytovale early sepsis detection system, discusses sepsis and COVID-19 and provides an overview of his pilot study.

Over half of residents with positive test results were asymptomatic at the time of testing, during a recent survey.

A trio of clinicians pen perspective on the federal and state efforts being made to reduce rapid and severe virus spread in at-risk facilities.

A pair of experts cite fair innings in their debate, wondering if age should play a role in deciding who qualifies for life-saving coronavirus treatments.

Tune in for a daily COVID-19 update.

Hypertension, obesity, and diabetes are the most observed comorbidities among infected patients in the New York City area.

New expert recommendations follow from evidence showing the virus is a thrombo-inflammatory process that can affect multiple organs in addition to the lungs.

Older patients who live alone are at a higher risk of being hospitalized for respiratory disease, according to a new study.

In part 2 of the interview, Ryan W. Stevens, PharmD, BCIDP, discusses the risks associated with convalescent plasma and highlights what clinicians should know.